...Emerging Healthcare Solutions received a sublicense from Regenetech to use NASA's Intrifuge Rotary Cell Culture System... ...treat liver disease. Further terms were not disclosed. Emerging Healthcare Solutions Inc. (Pink:EHSI), Houston, Texas Regenetech Inc....
...The university will use Regenetech's Intrifuge Bioreactor to develop a treatment for Type I diabetes using... ...to develop a treatment for Type I diabetes using a patient's own adult stem cells. Regenetech... ...the two-year deal and have an option to resulting IP. Financial terms were not disclosed. Regenetech Inc....
...Regenevita received exclusive rights to commercialize Regenetech's cellXpansion technology in Mexico. Regenevita will use the technology... ...cells from blood, which it will sell for R&D uses. Financial terms were not disclosed. Regenetech Inc....
...Emerging Healthcare Solutions received a sublicense from Regenetech to use NASA's Intrifuge Rotary Cell Culture System... ...treat liver disease. Further terms were not disclosed. Emerging Healthcare Solutions Inc. (Pink:EHSI), Houston, Texas Regenetech Inc....
...The university will use Regenetech's Intrifuge Bioreactor to develop a treatment for Type I diabetes using... ...to develop a treatment for Type I diabetes using a patient's own adult stem cells. Regenetech... ...the two-year deal and have an option to resulting IP. Financial terms were not disclosed. Regenetech Inc....
...Regenevita received exclusive rights to commercialize Regenetech's cellXpansion technology in Mexico. Regenevita will use the technology... ...cells from blood, which it will sell for R&D uses. Financial terms were not disclosed. Regenetech Inc....